Benzinga's Top Downgrades

Analysts at RBC Capital downgraded

United Technologies CorporationUTX

from Outperform to Sector Perform. United Technologies shares closed at $104.37 on Monday. Analysts at Leerink Swann downgraded

Sarepta Therapeutics IncSRPT

from Market Perform to Underperform. The target price for Sarepta Therapeutics has been lowered from $13 to $5. Sarepta Therapeutics shares fell 0.45 percent to $17.84 in pre-market trading. Wunderlich downgraded

Brocade Communications Systems, Inc. BRCD

from Buy to Hold. The target price for Brocade Communications has been lowered from $10.50 to $9. Brocade Communications shares declined 0.82 percent to $8.44 in pre-market trading. HSBC downgraded

Sanofi SA (ADR) SNY

from Buy to Hold. Sanofi shares dropped 1.25 percent to $40.94 in pre-market trading. Analysts at Barclays downgraded

Visteon CorpVC

from Overweight to Equal-weight. The target price for Visteon has been raised from $83 to $85. Visteon shares gained 1.04 percent to close at $80.50 on Monday. Canaccord Genuity downgraded

Barrick Gold Corporation (USA) ABX

from Buy to Hold. Barrick Gold shares rose 0.63 percent to $19.23 in pre-market trading.

Market News and Data brought to you by Benzinga APIs